- Home
- BGLC vs NUWE Comparison
BGLC vs NUWE Comparison
Compare BGLC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- NUWE
- Stock Information
- Founded
- BGLC 2017
- NUWE 1999
- Country
- BGLC Malaysia
- NUWE United States
- Employees
- BGLC N/A
- NUWE N/A
- Industry
- BGLC Medical Specialities
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BGLC Health Care
- NUWE Health Care
- Exchange
- BGLC Nasdaq
- NUWE Nasdaq
- Market Cap
- BGLC 5.8M
- NUWE 5.2M
- IPO Year
- BGLC N/A
- NUWE N/A
- Fundamental
- Price
- BGLC $0.25
- NUWE $1.00
- Analyst Decision
- BGLC
- NUWE Strong Buy
- Analyst Count
- BGLC 0
- NUWE 1
- Target Price
- BGLC N/A
- NUWE $17.00
- AVG Volume (30 Days)
- BGLC 1.5M
- NUWE 83.4K
- Earning Date
- BGLC 05-14-2025
- NUWE 05-06-2025
- Dividend Yield
- BGLC N/A
- NUWE N/A
- EPS Growth
- BGLC N/A
- NUWE N/A
- EPS
- BGLC N/A
- NUWE N/A
- Revenue
- BGLC $9,259,858.00
- NUWE $8,740,000.00
- Revenue This Year
- BGLC N/A
- NUWE $22.96
- Revenue Next Year
- BGLC N/A
- NUWE $29.97
- P/E Ratio
- BGLC N/A
- NUWE N/A
- Revenue Growth
- BGLC N/A
- NUWE N/A
- 52 Week Low
- BGLC $0.21
- NUWE $0.90
- 52 Week High
- BGLC $1.00
- NUWE $14.35
- Technical
- Relative Strength Index (RSI)
- BGLC 35.57
- NUWE 37.50
- Support Level
- BGLC $0.23
- NUWE $0.91
- Resistance Level
- BGLC $0.29
- NUWE $1.03
- Average True Range (ATR)
- BGLC 0.02
- NUWE 0.07
- MACD
- BGLC -0.01
- NUWE -0.02
- Stochastic Oscillator
- BGLC 20.22
- NUWE 32.26
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.